- Home
- CASI vs MYND Comparison
CASI vs MYND Comparison
Compare CASI & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- MYND
- Stock Information
- Founded
- CASI 1991
- MYND 1998
- Country
- CASI China
- MYND Cayman Islands
- Employees
- CASI N/A
- MYND N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- MYND Other Consumer Services
- Sector
- CASI Health Care
- MYND Real Estate
- Exchange
- CASI Nasdaq
- MYND Nasdaq
- Market Cap
- CASI 58.8M
- MYND 62.3M
- IPO Year
- CASI 1996
- MYND 2017
- Fundamental
- Price
- CASI $2.36
- MYND $1.27
- Analyst Decision
- CASI Strong Buy
- MYND
- Analyst Count
- CASI 1
- MYND 0
- Target Price
- CASI $6.00
- MYND N/A
- AVG Volume (30 Days)
- CASI 30.6K
- MYND 52.7K
- Earning Date
- CASI 11-15-2024
- MYND 02-05-2025
- Dividend Yield
- CASI N/A
- MYND N/A
- EPS Growth
- CASI N/A
- MYND N/A
- EPS
- CASI N/A
- MYND N/A
- Revenue
- CASI $22,055,000.00
- MYND $357,050,000.00
- Revenue This Year
- CASI N/A
- MYND N/A
- Revenue Next Year
- CASI $134.79
- MYND N/A
- P/E Ratio
- CASI N/A
- MYND N/A
- Revenue Growth
- CASI N/A
- MYND N/A
- 52 Week Low
- CASI $2.05
- MYND $0.61
- 52 Week High
- CASI $7.67
- MYND $5.57
- Technical
- Relative Strength Index (RSI)
- CASI 33.52
- MYND 32.17
- Support Level
- CASI $2.27
- MYND $1.27
- Resistance Level
- CASI $2.73
- MYND $1.72
- Average True Range (ATR)
- CASI 0.24
- MYND 0.16
- MACD
- CASI 0.02
- MYND -0.04
- Stochastic Oscillator
- CASI 12.70
- MYND 7.35
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.